Vivos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vivos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q2 2024.
  • Vivos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 3.4M shares, a 88.6% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.4M -26.5M -88.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 2.73M -27.2M -90.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.83M +913K +99.2% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 1.2M -21.8M -94.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 29.9M +6.92M +30.1% Jun 30, 2023 10-Q 2023-08-16
Q1 2023 29.9M +6.92M +30.1% Mar 31, 2023 10-Q 2023-06-08
Q4 2022 921K -22.1M -96% Dec 31, 2022 10-K/A 2024-07-30
Q3 2022 23M 0 0% Sep 30, 2022 10-Q 2022-12-20
Q2 2022 23M +200K +0.88% Jun 30, 2022 10-Q 2022-12-20
Q1 2022 23M +4.8M +26.4% Mar 31, 2022 10-Q/A 2022-11-25
Q4 2021 23M +4.8M +26.4% Dec 31, 2021 10-K 2023-03-30
Q3 2021 23M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 22.8M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 18.2M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 18.2M +5.77M +46.3% Dec 31, 2020 10-K 2022-03-31
Q4 2019 12.4M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.